NCT00711165View on ClinicalTrials.gov

Mometasone and Markers of Airway Inflammation

PHASE4CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

August 31, 2006

Conditions

Asthma

Interventions

DRUG

Placebo

2 puffs, qd

DRUG

Mometasone Furoate

400 mcg, qd for 8 weeks

Trial Locations (1)

68131

Creighton University Medical Center, Omaha

Sponsors

Collaborators (1)

Schering-Plough

All Listed Sponsors

collaborator

Schering-Plough

INDUSTRY

lead

Creighton University

OTHER

NCT00711165 - Mometasone and Markers of Airway Inflammation | Biotech Hunter | Biotech Hunter